CLINICAL TRIAL OF MEDICAL THERAPY IN BENIGN PROSTATIC HYPERPLASIA

良性前列腺增生药物治疗的临床试验

• 批准号: 6117943
• 负责人: JOE WESLEY RAMSDELL
• 金额: $ 1.46万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6117943
• 关键词: antihypertensive agents; antineoplastics; benign prostate hyperplasia; clinical research; clinical trials; finasteride; human subject; human therapy evaluation; male; neoplasm /cancer chemotherapy; neoplasm /cancer pharmacology; neoplastic growth; pathologic process

National Institutes of Health Benign Prostate Hyperplasia clinical trial to ascertain if finasteride and/or doxazosin delays or prevents the progression of benign prostate hyperplasia and whether drug therapy may be an appropriate alternative to surgery in some cases.

美国国立卫生研究院良性前列腺增生临床试验，以确定非那雄胺和/或多沙唑嗪是否延迟或阻止良性前列腺增生的进展，以及在某些情况下药物治疗是否可能是手术的合适选择。